This is an AMP page which is for mobile devices.
Link your Twitter Account to Market Wire News
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
home / articles / IMMX - What's Going On With Cancer-Focused Immix Biopharma Stock Today? | Benzinga
Immix Biopharma Inc (NASDAQ: IMMX) announced the presentation of updated data from the ongoing Phase 1b/2 NEXICART-1 study of its NXC-201, an autologous, BCMA-targeted chimeric antigen receptor T (CAR-T) cell therapy.
The updated dataset consists of 63 multiple myeloma patients.
95% overall response rate (36 of 38 patients at the therapeutic dose of 800 million CAR+T cells) in ...
News, Short Squeeze, Breakout and More Instantly...
Market Wire News is a media platform, the information on this page was provided by Benzinga via Quote Media. Read our full disclaimer.